Prognostic Value of Hematological Inflammatory Indices (PLR, NLR, SII) in Medium and High‐Risk Papillary Thyroid Carcinoma: A Multicenter Cohort Study

医学 内科学 价值(数学) 胃肠病学 多中心研究 甲状腺功能不全 前瞻性队列研究 队列研究 队列 内分泌学 回顾性队列研究 临床试验 试验预测值 甲状腺 梅德林
作者
Canxiao Li,Shijie Li,Yishen Zhao,Daqi Zhang,Yantao Fu,Le Zhou,Jingting Li,Fang Li,Rui Du,Nan Liang,Hui Sun
出处
期刊:Clinical Endocrinology [Wiley]
卷期号:104 (3): 255-269
标识
DOI:10.1111/cen.70046
摘要

BACKGROUND: Patients with medium and high-risk papillary thyroid carcinoma (PTC) demonstrate significantly poorer clinical outcomes compared to their low-risk counterparts. However, current prognostic stratification for this patient population remains suboptimal due to the absence of reliable biomarkers. This investigation aims to evaluate the clinical utility and prognostic potential of three hematological inflammatory indices: the platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) in medium and high-risk PTC cases. METHODS: This study analyzed 1070 PTC patients from the "DTCC study" (2014-2016), a multicenter prospective cohort investigating the initial management of differentiated thyroid cancer (DTC) in China. Preoperative hematological parameters (including PLR, NLR, and SII) and baseline clinical characteristics were evaluated to assess their prognostic significance. RESULTS: In medium and high-risk PTC patients, PLR ≤ 115.6 predicted increased recurrence risk (OR = 4.579, 95% CI: 1.863-11.255, p = 0.001) and worse disease-free survival (DFS; p = 0.001). Multivariate Cox regression confirmed PLR ≤ 115.6 as an independent prognostic factor for reduced DFS (HR = 3.080, 95% CI: 1.115-8.507, p = 0.030). Notably, this association persisted in intermediate-risk patients. Among high-risk PTC patients, however, SII ≤ 360.9 (rather than PLR) demonstrated stronger predictive value for recurrence (OR = 15.154, 95% CI: 1.873-122.640, p = 0.011). Consistently, multivariate analysis identified SII ≤ 360.9 as an independent risk factor for shorter DFS (HR = 14.399, 95% CI: 1.823-113.730, p = 0.011). CONCLUSION: Our findings demonstrate that PLR and SII emerged as risk stratification-specific prognostic biomarkers: PLR independently predicted prognosis in intermediate-risk cases, while SII showed superior predictive value for prognosis in high-risk patients. The differential utility of these indices-PLR for intermediate-risk stratification patients and SII for high-risk stratification patients-highlights their complementary roles in clinical decision-making. As routinely available, cost-effective inflammatory markers, PLR and SII may enhance risk-adapted surveillance strategies, though further validation is warranted to standardize cutoff values and integrate them into existing clinical management systems. TRIAL REGISTRATION: The trial was registered at ClinicalTrials. gov under the identifier NCT02638077.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
喔吼发布了新的文献求助10
刚刚
刚刚
Ava的应助被GIN采纳,获得25
1秒前
细腻飞鸟发布了新的文献求助10
2秒前
Orange的应助被red采纳,获得10
2秒前
Brave发布了新的文献求助10
3秒前
往往发布了新的文献求助20
3秒前
小二郎的应助被入司采纳,获得10
3秒前
隐形曼青的应助被gshsj采纳,获得10
3秒前
何文鑫发布了新的文献求助10
3秒前
直率海莲发布了新的文献求助10
3秒前
如意白猫发布了新的文献求助10
4秒前
小蘑菇的应助被你好天空采纳,获得10
4秒前
共享精神的应助被你好天空采纳,获得10
4秒前
汉堡包的应助被你好天空采纳,获得10
4秒前
科研通AI6.3的应助被你好天空采纳,获得10
4秒前
JJKK的应助被你好天空采纳,获得10
4秒前
Akim的应助被你好天空采纳,获得10
4秒前
Lucas的应助被你好天空采纳,获得10
4秒前
Nole的应助被你好天空采纳,获得10
4秒前
华仔的应助被蟹老板的crab采纳,获得10
5秒前
领导范儿的应助被你好天空采纳,获得10
5秒前
852的应助被Daodao采纳,获得10
5秒前
JJKK的应助被你好天空采纳,获得10
5秒前
zj发布了新的文献求助10
5秒前
5秒前
XU完成签到,获得积分10
6秒前
6秒前
派大星完成签到,获得积分10
6秒前
7秒前
7秒前
瘦瘦寻菡完成签到,获得积分20
7秒前
Nole的应助被Jingxue_ZX采纳,获得30
8秒前
lbh发布了新的文献求助10
8秒前
放青松完成签到,获得积分10
10秒前
Hello的应助被细腻飞鸟采纳,获得10
10秒前
10秒前
晚风轻吹完成签到,获得积分10
10秒前
可爱的函函的应助被火山采纳,获得10
11秒前
精明之瑶完成签到,获得积分20
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192250
求助须知:如何正确求助?哪些是违规求助? 9578881
关于积分的说明 21862513
捐赠科研通 7791814
什么是DOI,文献DOI怎么找? 3436868
关于科研通互助平台的介绍 2560584
邀请新用户注册赠送积分活动 2483698